Value-based pricing won’t encourage innovation, says ABPI
September 23, 2011Sales and Marketing value-based pricing
The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …
NHS ‘wasted’ £625 million on modern insulin
September 23, 2011Sales and Marketing diabetes, insulin
The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …
Healthcare 2025: what the future holds for pharma
September 22, 2011Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing
We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …
J&J’s hep C drug Incivo approved in Europe
September 22, 2011Sales and Marketing Incivek, Incivo, Victrelis
J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …
Sanofi spots acne vaccine opportunity
September 22, 2011Research and Development Sanofi, acne, dermatology
Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …
Pfizer to cut 11% of its workforce in Spain
September 22, 2011Sales and Marketing Pfizer, Spain, job cuts
Pfizer will cut 220 jobs in Spain as the government reduces spending on pharmaceuticals to help offset its growing debt …
RSA boosts team with new appointments
September 22, 2011Business Services appointment, business services
Global life sciences executive search and interim management firm RSA has made a series of new appointments across its practices. …
Health secretary calls for global action on lifestyle conditions
September 21, 2011cardiovascular, diabetes, respiratory, smoking
Health secretary Andrew Lansley has urged governments across the world to be “bold and determined” in working together to tackle …
NHS reforms face pressure from the Lords
September 21, 2011NHS reform
Peers are starting to voice their criticism of the government’s planned NHS reforms as the Health and Social Bill passes …
Obama proposes seven year rule for biologics
September 21, 2011Research and Development, Sales and Marketing Obama, biologics
President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
Silence Therapeutics appoints Thomas Christely
September 21, 2011Research and Development appointment, research and development
UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …
Pfizer to invest $200m in Irish biomanufacturing plant
September 21, 2011Manufacturing and Production Ireland, Pfizer, pharma manufacturing news
Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …
Janssen’s Zytiga launched in the UK
September 21, 2011Sales and Marketing Zytiga, prostate cancer
Janssen’s new advanced prostate cancer treatment Zytiga has been launched in the UK. Zytiga (abiraterone acetate) has been shown in …
Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme
September 20, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates
A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …
Roche to show new cancer data at European congress
September 20, 2011Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin
Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …
Boehringer’s Trajenta launched in the UK
September 20, 2011Sales and Marketing Boehringer, Trajenta, diabetes
Boehringer Ingelheim has launched its new diabetes drug Trajenta in the UK, with a price tag to match its rival …
Teva makes commitment to Russian manufacturing facility
September 20, 2011Manufacturing and Production, Sales and Marketing Russia, Teva
Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …
Intersex fish add to concerns about pharma wastewater
September 20, 2011Business Services, Manufacturing and Production Contamination, pharma manufacturing news
Researchers in France have discovered that wild fish living downstream from a pharmaceutical production plant making steroid drugs show serious …
Merck licences new MS drug
September 19, 2011Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301
Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
Alkermes and Elan Drug Technologies complete merger
September 19, 2011Manufacturing and Production Alkermes, Elan, pharma manufacturing news
The contract manufacturing and development unit of Irish drugmaker Elan has completed a near-$1 billion merger with drug delivery specialist …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
